Question 1

How many shares of NRXP does BlackRock, Inc. own?

Accepted Answer

As of 2026-Q2, BlackRock, Inc. holds 220,460 shares of NRXP (NRX PHARMACEUTICALS INC).

Question 2

What is BlackRock, Inc.'s NRXP position worth?

Accepted Answer

As of 2026-Q2, BlackRock, Inc.'s NRXP position is worth $901,681.

Question 3

Is BlackRock, Inc. buying or selling NRXP?

Accepted Answer

In 2026-Q2, BlackRock, Inc. increased their NRXP position (+122.7% change in shares).

Question 4

When did BlackRock, Inc. first buy NRXP?

Accepted Answer

Based on available 13F filings, BlackRock, Inc. first reported a position in NRXP in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	220,460	+122.7%	$901,681	0.0%	$4.09	27
2026-Q1	Increased	98,995	+19.8%	$210,860	0.0%	$1.80	18
2025-Q4	Increased	82,654	+26.4%	$223,992	0.0%	$2.63	19
2025-Q3	Increased	65,412	+1.6%	$215,860	0.0%	$3.25	16
2025-Q2	Increased	64,400	+121.5%	$209,944	0.0%	$3.42	25
2025-Q1	Unchanged	29,075	0.0%	$59,604	0.0%	$2.03	0
2024-Q4	New	29,075	-	$63,965	0.0%	$1.53	32

NRXP7 quarters

NRXP
7 quarters